Jennifer Radewahn
Physician Assistant · Saginaw, MINPI 1134496292
Payments from drug & device makers
Across 342 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$685
- Novo Nordisk$666
- AstraZeneca$560
- Boehringer Ingelheim$536
- Abbott$394
- Amgen$316
- plus $3K from 30 others
What the payments were for
- Food & beverage$6,048100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 45 | $685 |
| Novo Nordisk | 43 | $666 |
| AstraZeneca(2 entities) | 34 | $560 |
| Boehringer Ingelheim | 31 | $536 |
| Abbott | 16 | $394 |
| Amgen | 16 | $316 |
| Novartis | 14 | $288 |
| Bayer | 17 | $287 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $281 |
| Astellas Pharma US Inc | 12 | $233 |
| Merck | 13 | $233 |
| Pfizer | 12 | $210 |
| Otsuka America Pharmaceutical, Inc. | 9 | $191 |
| GSK | 10 | $181 |
| Johnson & Johnson | 7 | $133 |
| Exact Sciences | 5 | $93 |
| Aimmune Therapeutics, Inc. | 3 | $75 |
| Sanofi-aventis U.S. LLC | 4 | $74 |
| Esperion Therapeutics, Inc. | 4 | $66 |
| E.r. Squibb & Sons, L.L.C. | 3 | $63 |
| Corcept Therapeutics | 4 | $61 |
| Amarin Pharma, Inc. | 3 | $58 |
| AbbVie | 3 | $55 |
| Dexcom, Inc. | 3 | $49 |
| Eisai Inc. | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Biogen | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Bioventus LLC | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $13 |
| IBSA Pharma Inc. | 1 | $12 |
How this compares
$6,048 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $107,537 |
| MounjaroTirzepatide | 70 | $94,661 |
| EliquisApixaban | 76 | $90,653 |
| TrulicityDulaglutide | 33 | $71,258 |
| JardianceEmpagliflozin | 39 | $59,283 |
| RybelsusSemaglutide | 20 | $36,998 |
| FarxigaDapagliflozin Propanediol | 14 | $19,165 |
| MyrbetriqMirabegron | 15 | $18,654 |
| ProliaDenosumab | 11 | $18,158 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $13,361 |
| Atorvastatin Calcium | 274 | $3,839 |
| Pitavastatin Calcium | 16 | $3,436 |
| Levothyroxine Sodium | 302 | $3,333 |
| Rosuvastatin Calcium | 179 | $3,210 |
| Losartan Potassium | 196 | $2,759 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $685 | $165,920103 claims |
| Novo NordiskOzempic, Rybelsus | $666 | $144,53589 claims |
| PfizerEliquis | $210 | $90,65376 claims |
| Boehringer IngelheimJardiance | $536 | $59,28339 claims |
| AstraZenecaFarxiga | $560 | $19,16514 claims |
| Astellas Pharma US IncMyrbetriq | $233 | $18,65415 claims |
| AmgenProlia | $316 | $18,15811 claims |
| GSKTrelegy Ellipta | $181 | $13,36122 claims |
| AbbVieSynthroid | $55 | $1,62621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Saginaw
- Emma OsterholzerSaginaw$14K
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.